XXI Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
XXI Wealth's VRTX Position: Q3 2026 in Review
XXI Wealth increased its Vertex Pharmaceuticals (VRTX) stake by 6.4% in Q3 2026, buying an estimated $15.4K and bringing the position to 502 shares worth $262K. The position accounts for 0.11% of the portfolio, ranked #204.
XXI Wealth first reported a position in VRTX in Q1 2026 and has held it in 3 quarters since. 1,793 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- XXI Wealth held 502 shares of Vertex Pharmaceuticals worth $262K as of Q3 2026.
- XXI Wealth bought 30 Vertex Pharmaceuticals shares in Q3 2026, an estimated $15.4K.
- Vertex Pharmaceuticals made up 0.11% of XXI Wealth's portfolio in Q3 2026, its #204 holding.
- XXI Wealth first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 1,793 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on XXI Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.